Effectiveness of combined priming in a late reproductive age patient with androgen deficiency in the assisted reproductive technology program

Gavisova A.A., Shevtsova M.A., Burduli A.G.

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia
Background: Late reproductive age is accompanied by a diminished ovarian reserve and a poor ovarian response as a result of physiological maturation and ovarian failure, and is a difficult problem in achieving pregnancy with one's own genetic material. Folliculogenesis of the active reproductive period is associated with sufficient androgen concentrations, which has been repeatedly shown in a model of women with polycystic ovary syndrome. The choice of the optimal method of treating infertility in late reproductive age women with androgen deficiency in the assisted reproductive technology program is currently the most discussed issue.
Case report: The paper describes a clinical case of using combined androgen priming and metabolic therapy to improve folliculogenesis and embryogenesis in the in vitro fertilization program - intracytoplasmic sperm injection in a late reproductive age patient with androgen deficiency.
Conclusion: The combined approach to treating infertility in women of late reproductive age demonstrates a better clinical effect than to using androgen priming only.

Keywords

androgen deficiency
androgen therapy
infertility
folliculogenesis
embryogenesis
dehydroepiandrosterone
dehydroepiandrosterone sulfate
metabolic therapy
L-tyrosine
inositol

References

  1. Бурдули А.Г. Андрогеновый статус у пациенток в программах ЭКО. Акушерство и гинекология. 2019; 3: 40-4. https://dx.doi.org/10.18565/aig.2019.3.40-44. [Burduli A.G. Androgen status in patients in IVF programs. Obstetrics and Gynecology. 2019; 3: 40-4. (in Russian)].
  2. Tarlatzis B.C., Zepiridis L., Grimbizis G., Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum. Reprod. Update. 2003; 9: 61-76. https://dx.doi.org/10.1093/humupd/dmg007.
  3. de Placido G., Mollo A., Alviggi C., Strina I., Varricchio M.T., Ranieri A. et al. Rescue of IVF cycles in pituitary down regulated normogonadothtopic young women characterized by a poor initial response to recombinant FSH. Hum. Reprod. 2001; 16(9): 1875-9. https://dx.doi.org/10.1093/humrep/16.9.1875.
  4. Богатырева Х.А., Мишиева Н.Г., Мартазанова Б.А., Лапина В.С., Абубакиров А.Н. Эффективность протоколов стимуляции функции яичников в различные фазы менструального цикла у пациенток со сниженным овариальным резервом. Акушерство и гинекология. 2017; 11: 78-83. [Bogatyreva H.A., Mishieva N.G., Martazanova B.A., Lapina V.S., Abubakirov A.N. Effectiveness of ovarian function stimulation protocols in various phases of the menstrual cycle in patients with reduced ovarian reserve. Obstetrics and Gynecology. 2017; 11: 78-83. (in Russian)]. https://dx.doi.org/10.18565/aig.2017.11.78-83.
  5. Подзолкова Н.М., Шамугия Н.Л., Борисова М.С., Аншина М.Б. Сравнение эффективности различных протоколов овариальной стимуляции у пациенток со сниженным овариальным резервом. Проблемы репродукции. 2019; 25(3): 91-8. [Podzolkova N.M., Shamugia N.L., Borisova M.S., Anshina M.B. Comparison of the effectiveness of various ovarian stimulation protocols in patients with reduced ovarian reserve. Problems of Reproduction. 2019; 25(3): 91-8. (in Russian)].
  6. Surrey E., Schoolcraft W.B. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive technologies. Fertil. Steril. 2000; 73(4): 667-76. https://dx.doi.org/10.1016/s0015-0282(99)00630-5.
  7. Braunstein G.D. Safety of testosterone treatment in postmenopausal women. Fertil. Steril. 2007; 88(1): 1-17. https://dx.doi.org/10.1016/j.fertnstert.2007.01.118.
  8. Гависова А.А., Иванец Т.Ю., Долгушина Н.В. Референсные интервалы для уровня андрогенов в крови у женщин раннего и позднего репродуктивного возраста. Акушерство и гинекология. 2021; 8: 127-32. [Gavisova A.A., Ivanets T.Yu., Dolgushina N.V. Reference intervals for blood androgen levels in women of early and late reproductive age. Obstetrics and Gynecology. 2021; 8: 127-32. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.8.127-132.
  9. Гависова А.А., Шевцова М.А., Цховребова Л.Т., Михайлова Н.Д., Николаева А.В. Применение дегидроэпиандростерона у пациентки с бесплодием и андрогенным дефицитом. Акушерство и гинекология. 2020; 11: 237-42. [Gavisova A.A., Shevtsova M.A., Tskhovrebova L.T., Mikhailova N.D., Nikolaeva A.V. The use of dehydroepiandrosterone in a patient with infertility and androgen deficiency. Obstetrics and Gynecology. 2020; 11, 237-42.(in Russian)]. https://dx.doi.org/10.18565/aig.2020.11.237-242.
  10. Burger H.G. Androgen production in women. Fertil. Steril. 2002; 77(Suppl. 4): S3-5. https://dx.doi.org/10.1016/s0015-0282(02)02985-0.
  11. Casson P.R., Lindsay M.S., Pisarska M.D., Carson S.A., Buster J.E. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum. Reprod. 2000; 15(10): 2129-32.https://dx.doi.org/10.1093/humrep/15.10.2129.
  12. Barad D., Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum. Reprod. 2006; 21(11):2845-9. https://dx.doi.org/10.1093/humrep/del254.
  13. Mihm M., Evans A.C. Mechanisms for dominant follicle selection in monovulatory species: a comparison of morphological, endocrine and intraovarian events in cows, mares and women. Reprod. Domest. Anim. 2008; 43(Suppl. 2): 48-56. https://dx.doi.org/10.1111/j.1439-0531.2008.01142.x.
  14. Brusco G.F., Mariani M. Inositol: effects on oocyte quality in patients undergoing ICSI. An open study. Eur. Rev. Med. Pharmacol. Sci. 2013; 17(22): 3095-102.
  15. Wiser A., Gonen O., Ghetler Y., Shavit T., Berkovitz A., Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum. Reprod. 2010; 25(10): 2496-500. https://dx.doi.org/10.1093/humrep/deq220.
  16. Sunkara S.K., Coomarasamy A. Androgen pre-treatment in poor responders undergoing controlled ovarian stimulation and IVF treatment. Fertil. Steril. 2011; 95(8): e73-4; author reply e75. https://dx.doi.org/10.1016/j.fertnstert.2011.04.083.
  17. Luti S., Fiaschi T., Magherini F., Modesti P.A., Piomboni P., Governini L. et al.Relationship between the metabolic and lipid profile in follicular fluid of women undergoing in vitro fertilization. Mol. Reprod. Dev. 2020; 87(9): 986-97.https://dx.doi.org/10.1002/mrd.23415.

Received 26.03.2022

Accepted 23.06.2022

About the Authors

Alla A. Gavisova, Ph.D., Leading Researcher at the 1st Gynecology Department, Academician V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia, gavialla@yandex.ru, 117997, Russia, Moscow, Ac. Oparina str., 4.
Marina A. Shevtsova, post-graduate student, Academician V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia, +7(911)039-13-20, marina_981995@mail.ru,
117997, Russia, Moscow, Ac. Oparina str., 4.
Anna G. Burduli, Ph.D., Senior Researcher at the Department of Assisted Reproductive Technologies in the Treatment of Infertility named after B.V. Leonov,
Academician V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia, burdulianna@gmail.com, 117997, Russia, Moscow, Ac. Oparina str., 4.

Authors' contributions: Gavisova A.A., Shevtsova M.A. – female follow-up and management, review on the topic of the publication, writing and executing the article, final approval of the version for publication; Burduli A.G. – review on the topic of the publication, writing and executing the article, final approval of the version for publication.
Conflicts of interest: The authors declare that there are no possible conflicts of interest.
Funding: The investigation has not been sponsored.
Patient Consent for Publication: The patient provided informed consent for the publication of her data.
For citation: Gavisova A.A., Shevtsova M.A., Burduli A.G. Effectiveness of combined priming in a late reproductive age patient with androgen deficiency in the assisted reproductive technology program.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2022; 7: 137-141 (in Russian)
https://dx.doi.org/10.18565/aig.2022.7.137-141

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.